GB9609262D0 - Peptide library and method - Google Patents

Peptide library and method

Info

Publication number
GB9609262D0
GB9609262D0 GBGB9609262.2A GB9609262A GB9609262D0 GB 9609262 D0 GB9609262 D0 GB 9609262D0 GB 9609262 A GB9609262 A GB 9609262A GB 9609262 D0 GB9609262 D0 GB 9609262D0
Authority
GB
United Kingdom
Prior art keywords
peptide library
library
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9609262.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford University Innovation Ltd
Original Assignee
Oxford University Innovation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford University Innovation Ltd filed Critical Oxford University Innovation Ltd
Priority to GBGB9609262.2A priority Critical patent/GB9609262D0/en
Publication of GB9609262D0 publication Critical patent/GB9609262D0/en
Priority to PCT/GB1997/001228 priority patent/WO1997042507A1/en
Pending legal-status Critical Current

Links

GBGB9609262.2A 1996-05-02 1996-05-02 Peptide library and method Pending GB9609262D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB9609262.2A GB9609262D0 (en) 1996-05-02 1996-05-02 Peptide library and method
PCT/GB1997/001228 WO1997042507A1 (en) 1996-05-02 1997-05-02 Peptide array and method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9609262.2A GB9609262D0 (en) 1996-05-02 1996-05-02 Peptide library and method

Publications (1)

Publication Number Publication Date
GB9609262D0 true GB9609262D0 (en) 1996-07-03

Family

ID=10793128

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9609262.2A Pending GB9609262D0 (en) 1996-05-02 1996-05-02 Peptide library and method

Country Status (2)

Country Link
GB (1) GB9609262D0 (en)
WO (1) WO1997042507A1 (en)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7615368B1 (en) 1994-06-17 2009-11-10 The Board Of Trustees Of The Leland Stanford Junior University Microarrays of polypeptides
WO2000063701A2 (en) * 1999-04-15 2000-10-26 The Board Of Trustees Of The Leland Stanford Junior University Microarrays of polypeptides
EP1158058A1 (en) * 2000-05-19 2001-11-28 Centre National De La Recherche Scientifique Compositions and methods suitable for nucleic acid analyses
EP1377827A2 (en) * 2001-04-10 2004-01-07 NMI Naturwissenschaftliches und Medizinisches Institut an der Universität Tübingen in Reutlingen Stiftung Bürgerlichen Rechts Method for determining analyte molecules in a sample
ES2319634T3 (en) * 2002-03-11 2009-05-11 Caprotec Bioanalytics Gmbh COMPOUNDS AND METHODS TO ANALYZE THE PROTEOM.
CA2513549C (en) 2003-01-16 2009-05-05 Hk Pharmaceuticals, Inc. Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
KR100690948B1 (en) 2004-06-17 2007-03-09 한국과학기술원 Method for Cell Surface Display of Target Proteins Using FadL of E. coli
KR100784261B1 (en) 2006-01-02 2007-12-11 한국과학기술원 Method for Cell Surface Displaying of Target Proteins Using Bacillus anthracis Exosporium
AU2010226726B8 (en) 2009-03-16 2014-08-14 Pangu Biopharma Limited Compositions and methods comprising histidyl-tRNA synthetase splice variants having non-canonical biological activities
EP2414513B1 (en) 2009-03-31 2015-10-28 Atyr Pharma, Inc. Compositions and methods comprising aspartyl-trna synthetases having non-canonical biological activities
AU2011248625B2 (en) 2010-04-26 2017-01-05 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of cysteinyl-tRNA synthetase
CN103096911B (en) 2010-04-27 2018-05-29 Atyr 医药公司 Treatment relevant with the protein fragments of Isoleucyl-tRNA synthetase, diagnosis and the innovation of antibody compositions are found
JP6008837B2 (en) 2010-04-28 2016-10-19 エータイアー ファーマ， インコーポレイテッド Innovative discovery of therapeutic, diagnostic and antibody compositions related to protein fragments of alanyl tRNA synthetase
US9068177B2 (en) 2010-04-29 2015-06-30 Atyr Pharma, Inc Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutaminyl-tRNA synthetases
AU2011246976B2 (en) 2010-04-29 2016-01-28 Allarity Therapeutics Europe ApS Methods and devices for predicting treatment efficacy
CN103097523B (en) 2010-04-29 2016-09-28 Atyr医药公司 The innovation for the treatment of, diagnosis and the antibody compositions relevant to the protein fragments of Asparaginyl-tRNA synthetase finds
WO2011139907A2 (en) 2010-04-29 2011-11-10 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of valyl trna synthetases
WO2011139986A2 (en) 2010-05-03 2011-11-10 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of arginyl-trna synthetases
CN105820252B (en) 2010-05-03 2020-07-21 Atyr 医药公司 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl- α -tRNA synthetases
AU2011248230B2 (en) 2010-05-03 2016-10-06 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of methionyl-tRNA synthetases
JP6008844B2 (en) 2010-05-04 2016-10-19 エータイアー ファーマ， インコーポレイテッド Innovative discovery of therapeutic, diagnostic and antibody compositions related to protein fragments of the p38 MULTI-tRNA synthetase complex
CN103200953B (en) 2010-05-14 2017-02-15 Atyr 医药公司 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-trna synthetases
JP6027965B2 (en) 2010-05-17 2016-11-16 エータイアー ファーマ， インコーポレイテッド Innovative discovery of therapeutic, diagnostic and antibody compositions related to protein fragments of leucyl-tRNA synthetase
JP5906237B2 (en) 2010-06-01 2016-04-20 エータイアー ファーマ， インコーポレイテッド Innovative discovery of therapeutic, diagnostic and antibody compositions related to protein fragments of lysyl tRNA synthetase
EP2593125B1 (en) 2010-07-12 2017-11-01 aTyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-trna synthetases
WO2012027611A2 (en) 2010-08-25 2012-03-01 Atyr Pharma, Inc. INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF TYROSYL-tRNA SYNTHETASES
CA2836836A1 (en) 2011-06-01 2012-12-06 Medical Prognosis Institute A/S Methods and devices for prognosis of cancer relapse
DK2814514T3 (en) 2012-02-16 2017-12-18 Atyr Pharma Inc Histidyl tRNA synthetases for the treatment of autoimmune and inflammatory diseases
WO2014085434A1 (en) 2012-11-27 2014-06-05 Pontificia Universidad Catolica De Chile Compositions and methods for diagnosing thyroid tumors
CN103245788B (en) * 2013-03-22 2015-01-21 赵树民 Peptide array synthesis technology for B cell antigen epitope screening
US10392667B2 (en) 2013-06-07 2019-08-27 Medical Prognosis Institute A/S Methods and devices for predicting treatment efficacy of fulvestrant in cancer patients
WO2016008048A1 (en) 2014-07-15 2016-01-21 Ontario Institute For Cancer Research Methods and devices for predicting anthracycline treatment efficacy
CN107405399B (en) 2015-01-02 2022-02-08 武田药品工业株式会社 Bispecific antibodies against plasma kallikrein and factor XII
US10913802B2 (en) 2015-07-21 2021-02-09 Dyax Corp. Monoclonal antibody inhibitor of factor XIIA

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1255586A (en) * 1984-07-24 1989-06-13 Hendrik M. Geysen Method of determining mimotopes
US5585275A (en) * 1992-09-02 1996-12-17 Arris Pharmaceutical Corporation Pilot apparatus for peptide synthesis and screening
JP3353278B2 (en) * 1992-12-24 2002-12-03 株式会社島津製作所 Method for fractionating peptide N-terminal fragment

Also Published As

Publication number Publication date
WO1997042507A1 (en) 1997-11-13

Similar Documents

Publication Publication Date Title
GB9609262D0 (en) Peptide library and method
AU2805995A (en) Combinatorial peptide library and method
EP0842293A4 (en) Peptide library and screening method
PL339268A1 (en) Rapid marking-out method and system
GB9609379D0 (en) Mechanism and method
HK1024746A1 (en) Positioning system and method
AU2438595A (en) Morpholino-subunit combinatorial library and method
HK1023025A1 (en) Interface system and method
EP0920014A4 (en) Editing device and editing method
EP1014873A4 (en) Cryosurgical system and method
GB2311192B (en) Data-transmitter-receiver and method of operation
GB2299491B (en) Decoder and method therefor
HUP9801990A3 (en) Peptide and method of obtaining it
HUP9700446A3 (en) Oilsuspension-concentrate and using thereof
PL340287A1 (en) Identifying method and system
GB9625870D0 (en) Satellite operating system and method
GB2317773B (en) Chroma-key method and arrangement
HK1021117A1 (en) Candy-toy and method thereof
GB2317496B (en) Chipshooter manufacturing system and method of operation
PL331523A1 (en) Azolotrizines and azolopyrimidines
EP0863668A4 (en) Editing device and editing method
EP0911829A4 (en) Editing system and editing method
GB2318356B (en) Composition and method
GB9616563D0 (en) Compounds and methods
GB9606272D0 (en) Gene and peptides